Grounded in science—evidence-based in every way

Everything we do, from the tests we perform through our treatment recommendations, uses an evidence-based approach, grounded in over thirty years of original scientific research.

Our proprietary portfolio of tests, the Boston Heart HDL Map™ and Boston Heart Cholesterol Balance™, have been performed on over 40,000 patients. Boston Heart’s exclusive test for Statin Induced Myopathy (SLCO1B1) Genotype has been validated in clinical research on over 15,000 patients.

We are passionate about ongoing discovery that yields solutions to predict, prevent, manage and reverse cardiovascular disease (CVD).

Our Research

Our Proprietary Portfolio

Other Advanced Cardiovascular Risk Tests

Publications & References